Denali Therapeutics Inc.
NASDAQDenali Therapeutics enters the second week of August with a useful tension at its core: short sellers are sitting on an elevated 10.9% of float but have been quietly trimming, while the Street has turned notably more constructive in July — a combination that goes some way to explaining the stock's 7.9% rally on the week to $24.83. The positioning picture is more cautious than…
Snapshot as of 10 Aug 2026
Denali Therapeutics enters the second week of August with a useful tension at its core: short sellers are sitting on an elevated 10.9% of float but have been quietly trimming, while the Street has turned notably more…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DNLI — free to start on ORTEX.
Sign up for free →Open DNLI on ORTEX